Plunkett Research Online: CureVac NV

CUREVAC NV (CVAC) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal i.....


CUREVAC NV

Ticker: CVAC
Exchange: NAS
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 49 707198830
Fax: 49 707198831101
Address: Friedrich-Miescher-Strasse 15
Tubingen, BW 72076 Germany

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Contacts Description

Alexander ZehnderCEO
Pierre KemulaCFO
See More
CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal i.....See More See More

$USD, In whole numbers2023202220212020201920182017
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture